We have recently demonstrated that, in GBM, EGFRvIII expression results in increased levels of phosphorylated AKT (pAKT) due to the PI3K pathway activation and SK1 inhibition exerted in decreased pAKT levels [31]. Here, SPHK1 is linked to glioblastoma.